Exposure to PS-NPs with different charges can impair the phosphorylation of AKT and FoxO1, and treatment with SC79 effectively rescued this process, and alleviated T2DM-like lesions. The gene discussed is FOXO1; the disease is type 2 diabetes mellitus.